How will gene editing change medicine and who will benefit?

Ian Sample speaks to Guardian science correspondent Hannah Devlin
about the latest developments and debates about gene editing to
emerge from a summit at the Francis Crick Institute in London. The
summit heard from the first person with sickle cell disease to be
treated with a technique known as Crispr. He also hears from Prof
Claire Booth about ensuring these cutting edge treatments are made
available to everyone who needs them. Help support our independent
journalism at theguardian.com/sciencepod